Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2016 Financial Results

Marinus Pharmaceuticals (MRNS) PT Raised to $3 at Jefferies

August 10, 2016 8:28 AM EDT

Jefferies analyst Brian Abrahams reiterated a Buy rating and boosted his price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $3.00 (from $2.50).

Abrahams commented, "Though it has taken some time for ganaxolone to find its optimal indications, based on its GABA mechanism, and promising data from... More